Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-936-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-03-10 to 2004-09-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- (2000)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Fatty acids, C16-18(even numbered) and C18 unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized
- Cas Number:
- 91995-81-2 / 157905-74-3 / 93334-15-7
- Molecular formula:
- n.a. (UVCB)
- IUPAC Name:
- Fatty acids, C16-18(even numbered) and C18 unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized
- Test material form:
- solid
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (Minimal Essential Medium; Seromed)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/ß-Naphthoflavone induced rat liver S9 (protein concentration 35.7 mg/mL and 28.9 mg/mL)
- Test concentrations with justification for top dose:
- Evaluated test concentrations:
Experiment I: without S9 mix/ 4 hrs exposure: 25.0, 50.0, 100.0 µg/mL
with S9 mix/ 4 hrs exposure: 37.5, 75.0, 300.0, 600.0 µg/mL
Experiment II: without S9 mix/ 18 hrs exposure: 6.3, 12.5, 25.0 µg/mL
without S9 mix/ 28 hrs exposure: 18.8 µg/mL
with S9 mix/4 hrs exposure:: 18.8, 37.5, 150.0, 300.0 µg/mL
Experiment III: with S9 mix/ 4 hrs exposure: 300.0, 400.0, 500.0 µg/mL
A table containing all exposure concentrations is given under "Any other informations of materials and methods" - Vehicle / solvent:
- deionised water
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium (MEM with 10 % FCS)
DURATION
- Exposure duration:
Experiment I: with and without S9 mix 4 hrs
Experiment II: without S9 mix 18 and 28 hrs; with S9 mix 4 hrs
Experiment III: with S9 mix 4 hrs
- Expression time (cells in growth medium): 14 hrs for the 4 hrs exposure groups, no for the 18 and 28 hrs groups.
- Fixation time (start of exposure up to fixation or harvest of cells): 18 and 28 hrs respectively
SPINDLE INHIBITOR (cytogenetic assays): Colcemid (0.2 µg/mL culture medium)
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 3 independent experiments, per group two parallel cultures were set up.
NUMBER OF CELLS EVALUATED: at least 100 methaphase plates were scored per culture. Breaks, fragments, deletions, exchanges, and chromosome disintegrations were recorded as structural chromosome aberrations. Gaps were recorded as well, but not included in the calculation of the aberration rates.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: number of polyploidy cells in 500 metaphase cells per culture
was determined (% polyploid metaphases) - Evaluation criteria:
- A test item is classified as non-clastogenic if:
- the number of induced structural chromosome aberrations in all evaluated dose groups is in the range of laboratories historical control data
(0.0 – 4.0 % aberrant cells, exclusive gaps).
and/or
- no significant increase of the number of structural chromosome aberrations is observed.
A test item is classified as clastogenic if:
- the number of induced structural chromosome aberrations is not in the range of our historical control data
(0.0 – 4.0 % aberrant cells, exclusive gaps).
and
- either a concentration-related or a significant increase of the number of structural chromosome aberrations is observed.
Although the inclusion of the structural chromosome aberrations is the purpose of this study, it is important to include the polyploids and
endoreduplications.
A test item can be classified as aneugenic if:
- the number of induced numerical aberrations is not in the range of laboratories historical control data (0.0 – 8.5 % polyploid cells) - Statistics:
- Statistical significance was confirmed by means of the Fisher´s exact test (p < 0.05).
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: water was chosen as solvent, test substance was suspended in deionised water immediately before treatment.
- Precipitation: was observed, corresponding concentrations were identified in the exposure concentration table under
"any other information on materials and methods".
RANGE-FINDING/SCREENING STUDIES:
In a range finding pre-test on toxicity cell numbers 24 hrs after start of treatment were scored as an indicator for cytotoxicity. Concentrations between 39.1 and 5000µg/mL were applied. Clear toxic effects were observed after 4 hrs treatment with 156.3 µg/mL and above in the absence of S9 mix and with 625µg/mL and above in the presence of S9 mix. In addition, 24 hrs continuous treatment with 78.1 µg/mL and above in the absence of S9 mix induced strong toxic effects.
In the pre-experiment, precipitation of the test item in culture medium was observed after treatment with 39.1 µg/mL and above in the absence and the presence of S9 mix. No relevant influence of the test item on the pH value or osmolarity was observed (solvent control 288 mOsm, pH 7.2 versus 323 mOsm and pH 7.2 at 5000 µg/mL).
ADDITIONAL INFORMATION ON CYTOTOXICITY:
In this study, cytotoxicity was observed in all cytogenetic experiments. In the presence of S9 mix the cell numbers were strongly reduced after treatment with 600 µg/mL (32 % of control) at the 18 hrs preparation interval and with 500µg/mL (43 % if control) at the 28 hrs preparation interval.
MAIN TEST:
In experiment I and II, in the absence and the presence of S9 mix, no biological relevant increase in the number of cells carrying structural chromosome aberrations was observed. The aberration rates of the cells after treatment with the test item (0.0 - 4.8 % abberant cells, exclusive gaps) were close to the range of the solvent control values (0.0 – 1.5 % aberrant cells, exclusive gaps) and close to the range of our historical control data (0.0 – 4.0 % aberrant cells, exclusive gaps).
In the presence of S9 mix two significant (p < 0.05) increases were observed, in experiment I at preparation interval 18 hrs after treatment with 37.5 µg/mL (4 % aberrant cells, exclusive gaps), and in experiment II at preparation interval 28 hrs with 300 µg/mL (4.8 % aberrant cells, exclusive gaps). To prove this slightly increase value exceeding the upper border of our laboratory´s historical control data range an increased sample of 200 metaphase plates per culture was evaluated for cytogenetic damage.
However, the borderline value was confirmed. In addition, a dose related increase in the number of cells carrying structural chromosome aberrations (0.5 %, 2.5 % and 4.8 %) was observed after 4 hrs treatment at 28 hrs preparation interval in the presence of metabolic activation at the upper concentrations evaluated (37.5, 150.0 and 300.0 µg/mL) respectively.
A confirmatory experiment, designated experiment III, was performed to proof these observations. In the repeated experiment in the presence of S9 mix after 4 hrs treatment at prolonged 28 hrs preparation interval no biologically relevant increase in the number of cells carrying structural chromosome aberrations was observed. The aberration rates of the cells after treatment with the test item (1.0 – 3.0 % aberrant cells exclusive gaps) were close to the value of the solvent control (1.5 % aberrant cells, exclusive gaps) and within the range of our historical control data, (0.0 – 4.0 % aberrant cells, exclusive gaps).
Beside the aberration rates were dose related increased (1.0 %, 1.5 % and 3.0 %) in the concentration range evaluated (300 to 500 mg/mL), but the values were clearly within our laboratory´s control data range (0.0 – 4.0 % aberrant cells, exclusive gaps). Finally, the observations of experiment II in the presence of S9 mix (statistical significance, dose dependency, and borderline value) were not confirmed in experiment III and therefore they have to be regarded as biologically irrelevant.
In all experiments, no biologically relevant increase in the rate of polyploid metaphases was found after treatment with the test item (0.9 – 2.5 %) as compared to the rates of the solvent controls (1.9 – 3.0 %).
EMS and CPA were used as positive controls and showed distinct increase in cells with structural chromosome aberrations.
Applicant's summary and conclusion
- Conclusions:
- It can be stated that under the experimental conditions reported, the test item did not induce structural chromosome aberrations as determined by the chromosome aberration test in V79 cells (Chinese hamster cell line) in vitro. The test item is considered to be non-clastogenic in this chromosome aberration test with and without S9 mix when tested up to cytotoxic test item concentrations.
- Executive summary:
In a mammalian cell cytogenetics assay according to OECD Guideline 473, 1997 and EU Method B.10, 2000, V79 cell cultures were exposed to partially unsaturated TEA-Esterquat at concentration ranges of 3.1 – 200 µg/mL without metabolic activation and 4.7 – 600 µg/mL in the presence of mammalian metabolic activation. The following concentrations were selected for microscopic analysis:
Experiment I: without S9 mix/ 4 hrs exposure: 25.0, 50.0, 100.0 µg/mL
with S9 mix/ 4 hrs exposure: 37.5, 75.0, 300.0, 600.0 µg/mL
Experiment II: without S9 mix/ 18 hrs exposure: 6.3, 12.5, 25.0 µg/mL
without S9 mix/ 28 hrs exposure: 18.8 µg/mL
with S9 mix/4 hrs exposure:: 18.8, 37.5, 150.0, 300.0 µg/mL
Experiment III: with S9 mix/ 4 hrs exposure: 300.0, 400.0, 500.0 µg/mL
In experiment I and II, in the absence and the presence of S9 mix, no biological relevant increase in the number of cells carrying structural chromosome aberrations was observed. The aberration rates of the cells after treatment with the test item (0.0 - 4.8 % abberant cells, exclusive gaps) were close to the range of the solvent control values (0.0 – 1.5 % aberrant cells, exclusive gaps) and close to the range of our historical control data (0.0 – 4.0 % aberrant cells, exclusive gaps).
In the presence of S9 mix two significant (p < 0.05) increases were observed, in experiment I at preparation interval 18 hrs after treatment with 37.5 µg/mL (4 % aberrant cells, exclusive gaps), and in experiment II at preparation interval 28 hrs with 300 µg/mL (4.8 % aberrant cells, exclusive gaps). To prove this slightly increase value exceeding the upper border of our laboratory´s historical control data range an increased sample of 200 metaphase plates per culture was evaluated for cytogenetic damage.
However, the borderline value was confirmed. In addition, a dose related increase in the number of cells carrying structural chromosome aberrations (0.5 %, 2.5 % and 4.8 %) was observed after 4 hrs treatment at 28 hrs preparation interval in the presence of metabolic activation at the upper concentrations evaluated (37.5, 150.0 and 300.0 µg/mL) respectively.
A confirmatory experiment III was performed to proof these observations. In the repeated experiment in the presence of S9 mix after 4 hrs treatment at prolonged 28 hrs preparation interval no biologically relevant increase in the number of cells carrying structural chromosome aberrations was observed. The aberration rates of the cells after treatment with the test item (1.0 – 3.0 % aberrant cells exclusive gaps) were close to the value of the solvent control (1.5 % aberrant cells, exclusive gaps) and within the range of our historical control data, (0.0 – 4.0 % aberrant cells, exclusive gaps).
Beside the aberration rates were dose related increased (1.0 %, 1.5 % and 3.0 %) in the concentration range evaluated (300 to 500 mg/mL), but the values were clearly within our laboratory´s control data range (0.0 – 4.0 % aberrant cells, exclusive gaps). Finally, the observations of experiment II in the presence of S9 mix (statistical significance, dose dependency, and borderline value) were not confirmed in experiment III and therefore they have to be regarded as biologically irrelevant.
In all experiments, no biologically relevant increase in the rate of polyploid metaphases was found after treatment with the test item (0.9 – 2.5 %) as compared to the rates of the solvent controls (1.9 – 3.0 %).
Positive controls induced the appropriate response. EMS and CPA were used as positive controls and showed distinct increase in cells with structural chromosome aberrations.
In conclusion it can be stated that under the experimental conditions reported, the test item did not induce structural chromosome aberrations as determined by the chromosome aberration test in V79 cells (Chinese hamster cell line) in vitro. The test item is considered to be non-clastogenic in this chromosome aberration test with and without S9 mix when tested up to cytotoxic test item concentrations.
There was no evidence of chromosome aberration induced over background.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)